BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 4, 2012
View Archived Issues
Studies examine effects of aleglitazar on lipoproteins and aspirin-induced renal dysfunction
Read More
First-in-class oxaborole antibiotic shows potential to treat lung infections
Read More
AZD-8055 analogue shows promise to treat of hormone therapy-resistant tumors
Read More
Ketolide displays activity against Neisseria gonorrhoeae
Read More
FORMA Therapeutics presents novel Nampt inhibitors
Read More
Novel mouse model of atherosclerotic plaque rupture designed in Australia
Read More
DNA-intercalating antibacterial displays broad range of activity
Read More
Bionure neuroprotective drug set to enter clinic next year
Read More
Phase IIb study of eteplirsen meets primary endpoint
Read More
Forest Laboratories acquires intellectual property from Janssen
Read More
Astellas and Vical finalize design of pivotal CMV vaccine trial
Read More
First stage of phase III study of Reolysin completes enrollment
Read More
Hutchinson MediPharma presents potent dual PI3K/mTOR inhibitor
Read More
Phase III palifosfamide study advances
Read More
Novel protein kinase inhibitors reported by Ambit Biosciences
Read More
Gruenenthal discloses new bradykinin B1 receptor antagonists
Read More
FDA approves transdermal rotigotine patch for PD and RLS
Read More
Amgen and AstraZeneca to jointly develop inflammation portfolio candidates
Read More
Onyx Pharmaceuticals reports phase III regorafenib data
Read More
Medistem stem cell product to be evaluated in traumatic brain injury
Read More
Ajinomoto in-licenses IBAT inhibitor
Read More
Scripps Research Institute obtains funds to study new pathway in lymphoma
Read More
GSK gives update on phase III Harmony program
Read More
Marina Biotech completes dosing second cohort in START-FAP trial
Read More
AlloCure raises funds to support AC-607 development
Read More
Pfizer drug approved in Japan for ALK-positive NSCLC
Read More